Matches in Nanopublications for { ?s ?p "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP271031.RATz29hDlEJ4he5Hoh9jlzqn5AdGyZUdOjVokGTCcBwec130_assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271031.RATz29hDlEJ4he5Hoh9jlzqn5AdGyZUdOjVokGTCcBwec130_provenance.
- assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP260829.RA8W8oCat9dEOMj7CwtMXGbnoHFgjGH6v--nu_7hMCzwg130_assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260829.RA8W8oCat9dEOMj7CwtMXGbnoHFgjGH6v--nu_7hMCzwg130_provenance.
- NP825086.RAFPRVOKQXtfEWlT4J8XgpgEHOfbbicE9dIcEG-7ohNIA130_assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825086.RAFPRVOKQXtfEWlT4J8XgpgEHOfbbicE9dIcEG-7ohNIA130_provenance.
- NP798378.RA5aCHP63vBAhfJtMqDhRGWSVZdt_VEGslw1Jt3kae1-o130_assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798378.RA5aCHP63vBAhfJtMqDhRGWSVZdt_VEGslw1Jt3kae1-o130_provenance.
- NP1054317.RA3yXvyTKW9OEFW79CCEDniQsCYHx1KMB1D-9dnYAqj7o130_assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1054317.RA3yXvyTKW9OEFW79CCEDniQsCYHx1KMB1D-9dnYAqj7o130_provenance.
- NP1054315.RAXBkYLPd43g9KkAKiKqMaWMIq_xzWZTUsF1caKdaF4hg130_assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1054315.RAXBkYLPd43g9KkAKiKqMaWMIq_xzWZTUsF1caKdaF4hg130_provenance.
- assertion description "[Together with the observation that DEC1 bound directly to the promoter region of cyclin D1 in A549 cells, these results indicate that loss of DEC1 may promote tumor progression in NSCLC through upregulation of cyclin D1, and DEC1 might serve as a novel therapeutic target of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.